Showing results (11-20 of 52) with videos related to
Sort By:
Pageof 6
Molecular Therapy : the Journal of the American Society of Gene Therapy|March 19, 2009
Oncolytic reovirus effectively targets breast cancer stem cellsPaola Marcato, Cheryl A Dean, Carman A Giacomantonio, et al.Oncotarget|December 23, 2011
DNA-PKCS binding to p53 on the p21WAF1/CIP1 promoter blocks transcription resulting in cell deathRichard Hill, Patricia A Madureira, David M Waisman, et al.Biotechnology and Bioengineering|March 3, 2004
Optimization of reovirus production from mouse L-929 cells in suspension cultureSunghoon Jung, Leo A Behie, Patrick W K Lee, et al.Plos One|December 11, 2012
Genotoxic agents promote the nuclear accumulation of annexin A2: role of annexin A2 in mitigating DNA damagePatricia A Madureira, Richard Hill, Patrick W K Lee, et al.Oncotarget|October 1, 2019
Retraction: DNA-PKCS binding to p53 on the p21 promoter blocks transcription resulting in cell deathRichard Hill, Patricia A Madureira, David M Waisman, et al.Cancer Research|May 27, 2010
Oncogenic Ras promotes reovirus spread by suppressing IFN-beta production through negative regulation of RIG-I signalingMaya Shmulevitz, Lu-Zhe Pan, Katy Garant, et al.The Journal of Biological Chemistry|January 24, 2002
Biogenesis of p53 involves cotranslational dimerization of monomers and posttranslational dimerization of dimers. Implications on the dominant negative effectChris D Nicholls, Kevin G McLure, Michael A Shields, et al.The Journal of Biological Chemistry|January 31, 2004
DNA-dependent protein kinase and checkpoint kinase 2 synergistically activate a latent population of p53 upon DNA damageMelissa T Jack, Richard A Woo, Noboru Motoyama, et al.Journal of Virology|April 26, 2012
Reovirus variants with mutations in genome segments S1 and L2 exhibit enhanced virion infectivity and superior oncolysisMaya Shmulevitz, Shashi A Gujar, Dae-Gyun Ahn, et al.Molecular Therapy : the Journal of the American Society of Gene Therapy|January 20, 2011
Oncolytic virus-initiated protective immunity against prostate cancerShashi A Gujar, D A Pan, Paola Marcato, et al.Pageof 6